Health, Medicine and Natural Healing 11

179,008 topics in this forum

1. for advocates: Perspectives on Biomarker and Surrogate Endpoint Evaluation

   By Guest guest, January 24, 2011
   • 0 replies
   • 45 views
   • 
   • Guest
   • January 24, 2011

2. HDAC inhibitors trials: CLL / Lymphoma

   By Guest guest, January 25, 2011
   • 0 replies
   • 68 views
   • 
   • Guest
   • January 25, 2011

3. Potential New Agents for Chronic Lymphocytic Leukemia Treatment.

   By Guest guest, January 26, 2011
   • 0 replies
   • 55 views
   • 
   • Guest
   • January 26, 2011

4. New And Complex Circuitry Revealed By Global View Of Blood Cell Development

   By Guest guest, January 28, 2011
   • 0 replies
   • 32 views
   • 
   • Guest
   • January 28, 2011

5. Molecular Network That Influences Development Of CLL Revealed By Study

   By Guest guest, January 28, 2011
   • 0 replies
   • 35 views
   • 
   • Guest
   • January 28, 2011

6. Unrealistic Optimism Common in Early Clinical Trials

   By Guest guest, January 29, 2011
   • 0 replies
   • 31 views
   • 
   • Guest
   • January 29, 2011

7. Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties

   By Guest guest, January 29, 2011
   • 0 replies
   • 38 views
   • 
   • Guest
   • January 29, 2011

8. Reduced Intensity Allogeneic Transplantation Provides High Event-Free And Overall Survival In Patients With Advanced Indolent B Cell Malignancies: CALGB 109901.

   By Guest guest, February 16, 2011
   • 0 replies
   • 37 views
   • 
   • Guest
   • February 16, 2011

9. Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia

   By Guest guest, February 15, 2011
   • 0 replies
   • 32 views
   • 
   • Guest
   • February 15, 2011

10. study of interest: for relapse b-cell lymphoma after allo SCT

    By Guest guest, February 11, 2011
    • 0 replies
    • 33 views
    • 
    • Guest
    • February 11, 2011

11. Risk for second malignancies in non-Hodgkin’s lymphoma survivors: a meta-analysis

    By Guest guest, February 10, 2011
    • 0 replies
    • 34 views
    • 
    • Guest
    • February 10, 2011

12. Studies recruiting for UNTREATED lymphoma / CLL / SLL

    By Guest guest, February 10, 2011
    • 0 replies
    • 32 views
    • 
    • Guest
    • February 10, 2011

13. FDA Says Drug Firms Didn't Finish Follow-Ups

    By Guest guest, February 9, 2011
    • 0 replies
    • 29 views
    • 
    • Guest
    • February 9, 2011

14. Update on Therapy of Chronic Lymphocytic Leukemia

    By Guest guest, February 9, 2011
    • 0 replies
    • 37 views
    • 
    • Guest
    • February 9, 2011

15. New legislation to address drug shortages

    By Guest guest, February 9, 2011
    • 0 replies
    • 26 views
    • 
    • Guest
    • February 9, 2011

16. NEJM report: role of public-sector research

    By Guest guest, February 10, 2011
    • 0 replies
    • 42 views
    • 
    • Guest
    • February 10, 2011

17. Studies recruiting for UNTREATED CLL /SLL/lymphoma

    By Guest guest, February 10, 2011
    • 0 replies
    • 37 views
    • 
    • Guest
    • February 10, 2011

18. A PATHOBIOLOGICAL ROLE OF THE INSULIN RECEPTOR IN CHRONIC LYMPHOCYTIC LEUKEMIA

    By Guest guest, February 10, 2011
    • 0 replies
    • 38 views
    • 
    • Guest
    • February 10, 2011

19. Find Trials based on many subtypes and treatment status

    By Guest guest, February 10, 2011
    • 0 replies
    • 27 views
    • 
    • Guest
    • February 10, 2011

20. Re: Update on Therapy of Chronic Lymphocytic Leukemia

    By Guest guest, February 11, 2011
    • 1 reply
    • 39 views
    • 
    • Guest
    • February 12, 2011

21. Gribben: How I treat CLL up front

    By Guest guest, February 13, 2011
    • 0 replies
    • 43 views
    • 
    • Guest
    • February 13, 2011

22. Marrow is Less Fixed and More Flexible than Thought

    By Guest guest, February 14, 2011
    • 0 replies
    • 28 views
    • 
    • Guest
    • February 14, 2011

23. case reports dismissed with a single word: anecdotal. But why?

    By Guest guest, February 15, 2011
    • 0 replies
    • 51 views
    • 
    • Guest
    • February 15, 2011

24. relapsed CLL: Does adding lumiliximab improve on FCR?

    By Guest guest, February 16, 2011
    • 0 replies
    • 31 views
    • 
    • Guest
    • February 16, 2011

25. B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage

    By Guest guest, February 16, 2011
    • 0 replies
    • 43 views
    • 
    • Guest
    • February 16, 2011